Global Oncology Targeted Therapy Supply, Demand and Key Producers, 2023-2029

Description

The global Oncology Targeted Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.

This report studies the global Oncology Targeted Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncology Targeted Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Targeted Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oncology Targeted Therapy total market, 2018-2029, (USD Million)
Global Oncology Targeted Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oncology Targeted Therapy total market, key domestic companies and share, (USD Million)
Global Oncology Targeted Therapy revenue by player and market share 2018-2023, (USD Million)
Global Oncology Targeted Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Oncology Targeted Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oncology Targeted Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology Targeted Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oncology Targeted Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oncology Targeted Therapy Market, Segmentation by Type
    Sorafenib
    Lenvatinib
    Regorafenib
    Osimertinib
    Anlotinib
    Alectinib
    Other

Global Oncology Targeted Therapy Market, Segmentation by Application
    Hospital
    Retail Pharmacy
    Other

Companies Profiled:
    Bayer
    Eisai
    Zelgen
    Cipla
    Natco Pharma
    AstraZeneca
    Novartis
    Roche
    Bristol-Myers Squibb
    Pfizer
    BEACON Pharma
    Jiangxi Shanxiang
    Yao Pharma
    CSPC
    CHIATAI Tianqing
    Simcere

Key Questions Answered
1. How big is the global Oncology Targeted Therapy market?
2. What is the demand of the global Oncology Targeted Therapy market?
3. What is the year over year growth of the global Oncology Targeted Therapy market?
4. What is the total value of the global Oncology Targeted Therapy market?
5. Who are the major players in the global Oncology Targeted Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oncology Targeted Therapy Introduction
    1.2 World Oncology Targeted Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Oncology Targeted Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Oncology Targeted Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Oncology Targeted Therapy Market Size (2018-2029)
        1.3.3 China Oncology Targeted Therapy Market Size (2018-2029)
        1.3.4 Europe Oncology Targeted Therapy Market Size (2018-2029)
        1.3.5 Japan Oncology Targeted Therapy Market Size (2018-2029)
        1.3.6 South Korea Oncology Targeted Therapy Market Size (2018-2029)
        1.3.7 ASEAN Oncology Targeted Therapy Market Size (2018-2029)
        1.3.8 India Oncology Targeted Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oncology Targeted Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oncology Targeted Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oncology Targeted Therapy Consumption Value (2018-2029)
    2.2 World Oncology Targeted Therapy Consumption Value by Region
        2.2.1 World Oncology Targeted Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Oncology Targeted Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Oncology Targeted Therapy Consumption Value (2018-2029)
    2.4 China Oncology Targeted Therapy Consumption Value (2018-2029)
    2.5 Europe Oncology Targeted Therapy Consumption Value (2018-2029)
    2.6 Japan Oncology Targeted Therapy Consumption Value (2018-2029)
    2.7 South Korea Oncology Targeted Therapy Consumption Value (2018-2029)
    2.8 ASEAN Oncology Targeted Therapy Consumption Value (2018-2029)
    2.9 India Oncology Targeted Therapy Consumption Value (2018-2029)

3 World Oncology Targeted Therapy Companies Competitive Analysis
    3.1 World Oncology Targeted Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oncology Targeted Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oncology Targeted Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Oncology Targeted Therapy in 2022
    3.3 Oncology Targeted Therapy Company Evaluation Quadrant
    3.4 Oncology Targeted Therapy Market: Overall Company Footprint Analysis
        3.4.1 Oncology Targeted Therapy Market: Region Footprint
        3.4.2 Oncology Targeted Therapy Market: Company Product Type Footprint
        3.4.3 Oncology Targeted Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oncology Targeted Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oncology Targeted Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Oncology Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Oncology Targeted Therapy Consumption Value Comparison
        4.2.1 United States VS China: Oncology Targeted Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oncology Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Oncology Targeted Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Oncology Targeted Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oncology Targeted Therapy Revenue, (2018-2023)
    4.4 China Based Companies Oncology Targeted Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Oncology Targeted Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oncology Targeted Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Oncology Targeted Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Oncology Targeted Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oncology Targeted Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Oncology Targeted Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Sorafenib
        5.2.2 Lenvatinib
        5.2.3 Regorafenib
        5.2.4 Osimertinib
        5.2.5 Anlotinib
        5.2.6 Alectinib
        5.2.7 Other
    5.3 Market Segment by Type
        5.3.1 World Oncology Targeted Therapy Market Size by Type (2018-2023)
        5.3.2 World Oncology Targeted Therapy Market Size by Type (2024-2029)
        5.3.3 World Oncology Targeted Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oncology Targeted Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Oncology Targeted Therapy Market Size by Application (2018-2023)
        6.3.2 World Oncology Targeted Therapy Market Size by Application (2024-2029)
        6.3.3 World Oncology Targeted Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Oncology Targeted Therapy Product and Services
        7.1.4 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Eisai
        7.2.1 Eisai Details
        7.2.2 Eisai Major Business
        7.2.3 Eisai Oncology Targeted Therapy Product and Services
        7.2.4 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Eisai Recent Developments/Updates
        7.2.6 Eisai Competitive Strengths & Weaknesses
    7.3 Zelgen
        7.3.1 Zelgen Details
        7.3.2 Zelgen Major Business
        7.3.3 Zelgen Oncology Targeted Therapy Product and Services
        7.3.4 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Zelgen Recent Developments/Updates
        7.3.6 Zelgen Competitive Strengths & Weaknesses
    7.4 Cipla
        7.4.1 Cipla Details
        7.4.2 Cipla Major Business
        7.4.3 Cipla Oncology Targeted Therapy Product and Services
        7.4.4 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Cipla Recent Developments/Updates
        7.4.6 Cipla Competitive Strengths & Weaknesses
    7.5 Natco Pharma
        7.5.1 Natco Pharma Details
        7.5.2 Natco Pharma Major Business
        7.5.3 Natco Pharma Oncology Targeted Therapy Product and Services
        7.5.4 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Natco Pharma Recent Developments/Updates
        7.5.6 Natco Pharma Competitive Strengths & Weaknesses
    7.6 AstraZeneca
        7.6.1 AstraZeneca Details
        7.6.2 AstraZeneca Major Business
        7.6.3 AstraZeneca Oncology Targeted Therapy Product and Services
        7.6.4 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 AstraZeneca Recent Developments/Updates
        7.6.6 AstraZeneca Competitive Strengths & Weaknesses
    7.7 Novartis
        7.7.1 Novartis Details
        7.7.2 Novartis Major Business
        7.7.3 Novartis Oncology Targeted Therapy Product and Services
        7.7.4 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Novartis Recent Developments/Updates
        7.7.6 Novartis Competitive Strengths & Weaknesses
    7.8 Roche
        7.8.1 Roche Details
        7.8.2 Roche Major Business
        7.8.3 Roche Oncology Targeted Therapy Product and Services
        7.8.4 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Roche Recent Developments/Updates
        7.8.6 Roche Competitive Strengths & Weaknesses
    7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Details
        7.9.2 Bristol-Myers Squibb Major Business
        7.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Product and Services
        7.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Bristol-Myers Squibb Recent Developments/Updates
        7.9.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.10 Pfizer
        7.10.1 Pfizer Details
        7.10.2 Pfizer Major Business
        7.10.3 Pfizer Oncology Targeted Therapy Product and Services
        7.10.4 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Pfizer Recent Developments/Updates
        7.10.6 Pfizer Competitive Strengths & Weaknesses
    7.11 BEACON Pharma
        7.11.1 BEACON Pharma Details
        7.11.2 BEACON Pharma Major Business
        7.11.3 BEACON Pharma Oncology Targeted Therapy Product and Services
        7.11.4 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 BEACON Pharma Recent Developments/Updates
        7.11.6 BEACON Pharma Competitive Strengths & Weaknesses
    7.12 Jiangxi Shanxiang
        7.12.1 Jiangxi Shanxiang Details
        7.12.2 Jiangxi Shanxiang Major Business
        7.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Product and Services
        7.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Jiangxi Shanxiang Recent Developments/Updates
        7.12.6 Jiangxi Shanxiang Competitive Strengths & Weaknesses
    7.13 Yao Pharma
        7.13.1 Yao Pharma Details
        7.13.2 Yao Pharma Major Business
        7.13.3 Yao Pharma Oncology Targeted Therapy Product and Services
        7.13.4 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Yao Pharma Recent Developments/Updates
        7.13.6 Yao Pharma Competitive Strengths & Weaknesses
    7.14 CSPC
        7.14.1 CSPC Details
        7.14.2 CSPC Major Business
        7.14.3 CSPC Oncology Targeted Therapy Product and Services
        7.14.4 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 CSPC Recent Developments/Updates
        7.14.6 CSPC Competitive Strengths & Weaknesses
    7.15 CHIATAI Tianqing
        7.15.1 CHIATAI Tianqing Details
        7.15.2 CHIATAI Tianqing Major Business
        7.15.3 CHIATAI Tianqing Oncology Targeted Therapy Product and Services
        7.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 CHIATAI Tianqing Recent Developments/Updates
        7.15.6 CHIATAI Tianqing Competitive Strengths & Weaknesses
    7.16 Simcere
        7.16.1 Simcere Details
        7.16.2 Simcere Major Business
        7.16.3 Simcere Oncology Targeted Therapy Product and Services
        7.16.4 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Simcere Recent Developments/Updates
        7.16.6 Simcere Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oncology Targeted Therapy Industry Chain
    8.2 Oncology Targeted Therapy Upstream Analysis
    8.3 Oncology Targeted Therapy Midstream Analysis
    8.4 Oncology Targeted Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oncology Targeted Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Oncology Targeted Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Oncology Targeted Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Oncology Targeted Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Oncology Targeted Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oncology Targeted Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Oncology Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Oncology Targeted Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Oncology Targeted Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Oncology Targeted Therapy Players in 2022
    Table 12. World Oncology Targeted Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Oncology Targeted Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Oncology Targeted Therapy Player
    Table 15. Oncology Targeted Therapy Market: Company Product Type Footprint
    Table 16. Oncology Targeted Therapy Market: Company Product Application Footprint
    Table 17. Oncology Targeted Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Oncology Targeted Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Oncology Targeted Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Oncology Targeted Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oncology Targeted Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Oncology Targeted Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Oncology Targeted Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oncology Targeted Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Oncology Targeted Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Oncology Targeted Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oncology Targeted Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Oncology Targeted Therapy Revenue Market Share (2018-2023)
    Table 29. World Oncology Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Oncology Targeted Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Oncology Targeted Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Oncology Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Oncology Targeted Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Oncology Targeted Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Bayer Basic Information, Area Served and Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Oncology Targeted Therapy Product and Services
    Table 38. Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Bayer Recent Developments/Updates
    Table 40. Bayer Competitive Strengths & Weaknesses
    Table 41. Eisai Basic Information, Area Served and Competitors
    Table 42. Eisai Major Business
    Table 43. Eisai Oncology Targeted Therapy Product and Services
    Table 44. Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Eisai Recent Developments/Updates
    Table 46. Eisai Competitive Strengths & Weaknesses
    Table 47. Zelgen Basic Information, Area Served and Competitors
    Table 48. Zelgen Major Business
    Table 49. Zelgen Oncology Targeted Therapy Product and Services
    Table 50. Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Zelgen Recent Developments/Updates
    Table 52. Zelgen Competitive Strengths & Weaknesses
    Table 53. Cipla Basic Information, Area Served and Competitors
    Table 54. Cipla Major Business
    Table 55. Cipla Oncology Targeted Therapy Product and Services
    Table 56. Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Cipla Recent Developments/Updates
    Table 58. Cipla Competitive Strengths & Weaknesses
    Table 59. Natco Pharma Basic Information, Area Served and Competitors
    Table 60. Natco Pharma Major Business
    Table 61. Natco Pharma Oncology Targeted Therapy Product and Services
    Table 62. Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Natco Pharma Recent Developments/Updates
    Table 64. Natco Pharma Competitive Strengths & Weaknesses
    Table 65. AstraZeneca Basic Information, Area Served and Competitors
    Table 66. AstraZeneca Major Business
    Table 67. AstraZeneca Oncology Targeted Therapy Product and Services
    Table 68. AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. AstraZeneca Recent Developments/Updates
    Table 70. AstraZeneca Competitive Strengths & Weaknesses
    Table 71. Novartis Basic Information, Area Served and Competitors
    Table 72. Novartis Major Business
    Table 73. Novartis Oncology Targeted Therapy Product and Services
    Table 74. Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Novartis Recent Developments/Updates
    Table 76. Novartis Competitive Strengths & Weaknesses
    Table 77. Roche Basic Information, Area Served and Competitors
    Table 78. Roche Major Business
    Table 79. Roche Oncology Targeted Therapy Product and Services
    Table 80. Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Roche Recent Developments/Updates
    Table 82. Roche Competitive Strengths & Weaknesses
    Table 83. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 84. Bristol-Myers Squibb Major Business
    Table 85. Bristol-Myers Squibb Oncology Targeted Therapy Product and Services
    Table 86. Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Bristol-Myers Squibb Recent Developments/Updates
    Table 88. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 89. Pfizer Basic Information, Area Served and Competitors
    Table 90. Pfizer Major Business
    Table 91. Pfizer Oncology Targeted Therapy Product and Services
    Table 92. Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Pfizer Recent Developments/Updates
    Table 94. Pfizer Competitive Strengths & Weaknesses
    Table 95. BEACON Pharma Basic Information, Area Served and Competitors
    Table 96. BEACON Pharma Major Business
    Table 97. BEACON Pharma Oncology Targeted Therapy Product and Services
    Table 98. BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. BEACON Pharma Recent Developments/Updates
    Table 100. BEACON Pharma Competitive Strengths & Weaknesses
    Table 101. Jiangxi Shanxiang Basic Information, Area Served and Competitors
    Table 102. Jiangxi Shanxiang Major Business
    Table 103. Jiangxi Shanxiang Oncology Targeted Therapy Product and Services
    Table 104. Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Jiangxi Shanxiang Recent Developments/Updates
    Table 106. Jiangxi Shanxiang Competitive Strengths & Weaknesses
    Table 107. Yao Pharma Basic Information, Area Served and Competitors
    Table 108. Yao Pharma Major Business
    Table 109. Yao Pharma Oncology Targeted Therapy Product and Services
    Table 110. Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Yao Pharma Recent Developments/Updates
    Table 112. Yao Pharma Competitive Strengths & Weaknesses
    Table 113. CSPC Basic Information, Area Served and Competitors
    Table 114. CSPC Major Business
    Table 115. CSPC Oncology Targeted Therapy Product and Services
    Table 116. CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. CSPC Recent Developments/Updates
    Table 118. CSPC Competitive Strengths & Weaknesses
    Table 119. CHIATAI Tianqing Basic Information, Area Served and Competitors
    Table 120. CHIATAI Tianqing Major Business
    Table 121. CHIATAI Tianqing Oncology Targeted Therapy Product and Services
    Table 122. CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. CHIATAI Tianqing Recent Developments/Updates
    Table 124. Simcere Basic Information, Area Served and Competitors
    Table 125. Simcere Major Business
    Table 126. Simcere Oncology Targeted Therapy Product and Services
    Table 127. Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Oncology Targeted Therapy Upstream (Raw Materials)
    Table 129. Oncology Targeted Therapy Typical Customers
List of Figure
    Figure 1. Oncology Targeted Therapy Picture
    Figure 2. World Oncology Targeted Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oncology Targeted Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Oncology Targeted Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oncology Targeted Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Oncology Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Oncology Targeted Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Oncology Targeted Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Oncology Targeted Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Targeted Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Targeted Therapy Markets in 2022
    Figure 27. United States VS China: Oncology Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oncology Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Oncology Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Oncology Targeted Therapy Market Size Market Share by Type in 2022
    Figure 31. Sorafenib
    Figure 32. Lenvatinib
    Figure 33. Regorafenib
    Figure 34. Osimertinib
    Figure 35. Anlotinib
    Figure 36. Alectinib
    Figure 37. Other
    Figure 38. World Oncology Targeted Therapy Market Size Market Share by Type (2018-2029)
    Figure 39. World Oncology Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Oncology Targeted Therapy Market Size Market Share by Application in 2022
    Figure 41. Hospital
    Figure 42. Retail Pharmacy
    Figure 43. Other
    Figure 44. Oncology Targeted Therapy Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source